Lundbeck
HLUN-B.CO
#2582
Rank
A$8.59 B
Marketcap
$9.02
Share price
-0.98%
Change (1 day)
29.06%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Cash on Hand

Cash on Hand as of September 2024 : A$1.99 Billion

According to Lundbeck 's latest financial reports the company has A$1.99 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lundbeck - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$1.08 B50.44%
2022-12-31A$0.72 B51.26%
2021-12-31A$0.47 B-43.26%
2020-12-31A$0.84 B30.78%
2019-12-31A$0.64 B-55.3%
2018-12-31A$1.44 B90.05%
2017-12-31A$0.75 B74.36%
2016-12-31A$0.43 B42.33%
2015-12-31A$0.30 B-58.21%
2014-12-31A$0.73 B-39.79%
2013-12-31A$1.21 B87.46%
2012-12-31A$0.64 B-3.16%
2011-12-31A$0.66 B62.39%
2010-12-31A$0.41 B-4.72%
2009-12-31A$0.43 B-58.03%
2008-12-31A$1.03 B160.09%
2007-12-31A$0.39 B49.87%
2006-12-31A$0.26 B166.98%
2005-12-31A$99.13 M-22.22%
2004-12-31A$0.12 B